NIH RePORTER
Cure8 regulatory brief
Why This Matters
Researchers are studying necroptosis — a form of inflammatory cell death — because it appears to contribute to inflammatory bowel disease and other inflammatory conditions. Understanding the molecular steps could point toward future biomarkers or targets for new treatments.
Who Should Pay Attention
Researchers studying cell-death pathways, basic scientists in immunology and molecular biology, and clinicians/researchers interested in IBD pathogenesis and translational targets.
Study Snapshot
Story typeRegulatory
Evidence typeFunded research project
Study statusFunded
Source depthResearch project record
What To Know
This is an NIH-funded R35 MIRA research project from UC Berkeley focused on defining molecular mechanisms of necroptosis, especially the ZBP1–RIPK3–MLKL pathway.
The summary describes plans to study how ZBP1 recognizes Z-form nucleic acids, how it assembles to activate RIPK3, and how MLKL changes conformation to form membrane pores; it also notes relevance of dysregulated necroptosis to dermatitis, inflammatory bowel disease, and neurodegeneration.
The project is described as five years of funded, exploratory basic research supported by an R35 award. The write-up is a project-record (not a completed study) and outlines aims and mechanistic goals rather than clinical results. It does not report patient data, trial outcomes, or therapeutic recommendations.
If you follow IBD research, this project matters because it investigates a cell-death pathway implicated in intestinal inflammation and could eventually inform biomarkers or new therapeutic targets, though clinical translation would require further work.
Keep In Mind
This entry is a funded project summary (R35 MIRA) describing planned basic-science work; it is not a peer-reviewed paper or clinical trial report. Any implications for patient care or therapies are speculative until follow-up studies show translational results.
Source Details
Review the original publication for the complete reporting, methods, and context.
Funded research project
Evidence type derived from source or registry metadata.
PublicationNIH RePORTER
AuthorsShiyu Xia
InstitutionUNIVERSITY OF CALIFORNIA BERKELEY
Study typeFunded Research Project
Indexed viaNIH RePORTER
Source typeFunded research record
PublishedAug 1, 2026, 12:00 AM
Content availableResearch project record
Funding disclosed by the source: National Institute of General Medical Sciences - R35GM166219 - $329,491
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Citrullination of cathepsin H promotes NETs formation and exacerbates IBD via PI3K-Akt pathway.
The study identifies a new molecular mechanism (CTSH citrullination) that appears to drive NETs formation and worsen colitis in mice, which could point toward future therapies targeting PAD4–CTSH–NETs pathways. That...
Research into protein could lead to new treatments
The study identifies a specific protein interaction that may underlie persistent inflammation; for people with Crohn’s and other inflammatory conditions this points to a potential new, more targeted treatment approach in...
Colonic Complement Factor B Production Is Required To Respond To Tissue Injury 2310076
If local complement Factor B helps the gut heal, it could change how researchers think about targeting complement in IBD — suggesting local regulation rather than systemic inhibition. That’s important because complement...